Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H22FN5O7 |
Molecular Weight | 487.4378 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12[C@H](C)O[C@H](C)CN1C3=C(CC24C(=O)NC(=O)NC4=O)C=C5C(=NOC5=C3F)N6[C@@H](C)COC6=O
InChI
InChIKey=ZSWMIFNWDQEXDT-ZESJGQACSA-N
InChI=1S/C22H22FN5O7/c1-8-7-33-21(32)28(8)17-12-4-11-5-22(18(29)24-20(31)25-19(22)30)16-10(3)34-9(2)6-27(16)14(11)13(23)15(12)35-26-17/h4,8-10,16H,5-7H2,1-3H3,(H2,24,25,29,30,31)/t8-,9+,10-,16+/m0/s1
Molecular Formula | C22H22FN5O7 |
Molecular Weight | 487.4378 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Zoliflodacin (also known as AZD0914 or ETX0914) is a spiropyrimidinetrione with activity against bacterial type II topoisomerases that inhibits DNA biosynthesis and results in accumulation of double-strand cleavages in bacteria. This drug is being a DNA gyrase inhibitor, targeting Neisseria gonorrhoeae and is currently in phase II clinical trial in adults to treat uncomplicated urogenital gonorrhea.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT02257918
AZD0914 (ZOLIFLODACIN) is an antimicrobial amorphous nonsterile powder. Group 1 receive 2000 mg; Group 2 receive 3000 mg.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:42:50 GMT 2023
by
admin
on
Sat Dec 16 09:42:50 GMT 2023
|
Record UNII |
FWL2263R77
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
300000009721
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
DTXSID101028418
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
1620458-09-4
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
DB12817
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
FWL2263R77
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
76685216
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
10285
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
Zoliflodacin
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
CHEMBL3544978
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
CD-63
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY | |||
|
C152962
Created by
admin on Sat Dec 16 09:42:50 GMT 2023 , Edited by admin on Sat Dec 16 09:42:50 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |